Showing results (1-10 of 171) with videos related to
Sort By:
Pageof 18
Medical Oncology and Tumor Pharmacotherapy|January 1, 1984
Long-term LHRH-agonist treatment in metastatic breast cancer as a single treatment and in combination with other additive endocrine treatmentsJ G KlijnNederlands Tijdschrift Voor Geneeskunde|April 29, 1998
[Hormone replacement therapy following breast carcinoma]J G Klijn, M BontenbalLancet (London, England)|May 29, 1982
Treatment with a luteinising-hormone-releasing-hormone analogue (buserelin) in premenopausal patients with metastatic breast cancerJ G Klijn, F H de JongClinical & Experimental Metastasis|January 1, 1997
Assessment of the invasive potential of human gynecological tumor cell lines with the in vitro Boyden chamber assay: influences of the ability of cells to migrate through the filter membraneA M Sieuwerts, J G Klijn, J A FoekensJournal of Endocrinological Investigation|October 1, 1980
The effect of tamoxifen on GH and PRL secretion by human pituitary tumorsS W Lamberts, M de Quijada, J G KlijnMolecular and Cellular Endocrinology|October 6, 1999
Insulin-like growth factor 1 (IGF-1) and urokinase-type plasminogen activator (uPA) are inversely related in human breast fibroblastsA M Sieuwerts, J G Klijn, J A FoekensEuropean Journal of Cancer & Clinical Oncology|December 1, 1985
Direct inhibitory effect of a luteinizing hormone-releasing hormone agonist on MCF-7 human breast cancer cellsM A Blankenstein, M S Henkelman, J G KlijnSteroids|December 8, 2000
Progesterone antagonists and progesterone receptor modulators in the treatment of breast cancerJ G Klijn, B Setyono-Han, J A FoekensCancer Surveys|January 1, 1993
Prognostic factors and response to therapy in breast cancerJ G Klijn, E M Berns, J A FoekensNederlands Tijdschrift Voor Geneeskunde|October 9, 1998
[Chemotherapy in metastasized breast carcinoma]M Bontenbal, R de Wit, J G Klijn, et al.Pageof 18